Cell or Cell Membrane-Based Drug Delivery Systems

Natural cells have been explored as drug carriers for a long period. They have received growing interest as a promising drug delivery system (DDS) until recently along with the development of biology and medical science. The synthetic materials, either organic or inorganic, are found to be with more or less immunogenicity and/or toxicity. The cells and extracellular vesicles (EVs), are endogenous and thought to be much safer and friendlier. Furthermore, in view of their host attributes, they may achieve different biological effects and/or targeting specificity, which can meet the needs of personalized medicine as the next generation of DDS. In this review, we summarized the recent progress in cell or cell membrane-based DDS and their fabrication processes, unique properties and applications, including the whole cells, EVs and cell membrane coated nanoparticles. We expect the continuing development of this cell or cell membrane-based DDS will promote their clinic applications.

[1]  James J Moon,et al.  Engineering Nano‐ and Microparticles to Tune Immunity , 2012, Advanced materials.

[2]  Donghong Zhao,et al.  Neural Stem Cell-Mediated Intratumoral Delivery of Gold Nanorods Improves Photothermal Therapy , 2014, ACS nano.

[3]  S. Grimaldi,et al.  Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: efficiency metabolism and activity against human immunodeficiency virus or herpes simplex virus. , 1997, Antiviral research.

[4]  Cui Tang,et al.  Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.

[5]  J. M. Lanao,et al.  Drug, enzyme and peptide delivery using erythrocytes as carriers. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Anne L. van de Ven,et al.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.

[7]  Ronnie H. Fang,et al.  Liposome-like Nanostructures for Drug Delivery. , 2013, Journal of materials chemistry. B.

[8]  M. Segura,et al.  Interaction of Mouse Dendritic Cells and Malaria-Infected Erythrocytes: Uptake, Maturation, and Antigen Presentation1 , 2006, The Journal of Immunology.

[9]  Vipul Gujrati,et al.  Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. , 2014, ACS nano.

[10]  Seung U. Kim,et al.  Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Ralph Weissleder,et al.  Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.

[12]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[13]  B. Badie,et al.  Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[14]  Peter Y. Li,et al.  Structural elucidation of cell membrane-derived nanoparticles using molecular probes. , 2014, Journal of materials chemistry. B.

[15]  Olivier Lantz,et al.  Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial , 2005, Journal of Translational Medicine.

[16]  C. Théry,et al.  Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. , 2008, Cancer research.

[17]  J. Le Pecq,et al.  A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer , 2005, Journal of Translational Medicine.

[18]  Cesar M. Castro,et al.  Magnetic nanosensor for detection and profiling of erythrocyte-derived microvesicles. , 2013, ACS nano.

[19]  Ronnie H. Fang,et al.  Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes , 2013, Advanced materials.

[20]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[21]  Ronnie H. Fang,et al.  Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery , 2014, Nano letters.

[22]  H. Gendelman,et al.  Cell-mediated drug delivery , 2011, Expert opinion on drug delivery.

[23]  M. Rumbo,et al.  Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection. , 2013, Vaccine.

[24]  Samir Mitragotri,et al.  Long Circulating Nanoparticles via Adhesion on Red Blood Cells: Mechanism and Extended Circulation , 2007, Experimental biology and medicine.

[25]  M. Kim,et al.  The influence of amphotericin B on the permeability of mammalian erythrocytes to nonelectrolytes, anions and cations , 1973 .

[26]  Shinobu Ueda,et al.  Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  S. Vinogradov,et al.  Macrophages associated with tumors as potential targets and therapeutic intermediates. , 2014, Nanomedicine.

[28]  Jian Song,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[29]  A Herráez,et al.  In vitro phagocytosis of carrier mouse red blood cells is increased by Band 3 cross‐linking or diamide treatment , 2001, Biotechnology and applied biochemistry.

[30]  R. Simpson,et al.  Proteomic profiling of exosomes: Current perspectives , 2008, Proteomics.

[31]  Ronnie H. Fang,et al.  Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release. , 2013, Nanomedicine.

[32]  R. Kerbel,et al.  Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR , 2009, Proceedings of the National Academy of Sciences.

[33]  V. Torchilin Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[34]  Helmuth Möhwald,et al.  Red blood cells and polyelectrolyte multilayer capsules: natural carriers versus polymer-based drug delivery vehicles , 2013, Expert opinion on drug delivery.

[35]  Dong Chen,et al.  Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. , 2011, ACS nano.

[36]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[37]  S. Kesari,et al.  Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Sang Joon Lee,et al.  Gold nanoparticle-incorporated human red blood cells (RBCs) for X-ray dynamic imaging. , 2011, Biomaterials.

[39]  C. Figdor,et al.  Dendritic cell-based nanovaccines for cancer immunotherapy. , 2013, Current opinion in immunology.

[40]  Feng Gao,et al.  Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. , 2014, ACS nano.

[41]  T. Tsong,et al.  Electroporation of cell membranes. , 1991, Biophysical journal.

[42]  S Gasic,et al.  In vivo clearance of antibody‐sensitized human drug carrier erythrocytes , 1986, Clinical pharmacology and therapeutics.

[43]  Ronnie H. Fang,et al.  Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. , 2014, Nanoscale.

[44]  Jaesung Park,et al.  Large-scale generation of cell-derived nanovesicles. , 2014, Nanoscale.

[45]  Jing Chen,et al.  RAFTsomes Containing Epitope-MHC-II Complexes Mediated CD4+ T Cell Activation and Antigen-Specific Immune Responses , 2012, Pharmaceutical Research.

[46]  Marcelle Machluf,et al.  Reconstructed stem cell nanoghosts: a natural tumor targeting platform. , 2013, Nano letters.

[47]  C. Heirman,et al.  Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy. , 2012, Cancer research.

[48]  F. Ahsan,et al.  Nano-Engineered Erythrocyte Ghosts as Inhalational Carriers for Delivery of Fasudil: Preparation and Characterization , 2014, Pharmaceutical Research.

[49]  Ronnie H. Fang,et al.  Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. , 2013, Nanoscale.

[50]  Liangfang Zhang,et al.  Erythrocyte‐Inspired Delivery Systems , 2012, Advanced healthcare materials.

[51]  Jiangxia Liu,et al.  Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity , 2013, Nature Immunology.

[52]  Shunsuke Noguchi,et al.  Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[53]  Laurence Zitvogel,et al.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming , 2001, Nature Medicine.

[54]  F. Rico,et al.  Structural and mechanical heterogeneity of the erythrocyte membrane reveals hallmarks of membrane stability. , 2013, ACS nano.

[55]  Jaesung Park,et al.  Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers. , 2014, Lab on a chip.

[56]  Y. Gho,et al.  Proteomics, transcriptomics and lipidomics of exosomes and ectosomes , 2013, Proteomics.

[57]  Q. Dong,et al.  Monitoring diclofenac sodium in single human erythrocytes introduced by electroporation using capillary zone electrophoresis with electrochemical detection , 2001, Electrophoresis.

[58]  Bahman Anvari,et al.  Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications , 2013, Scientific Reports.

[59]  R. Schiffelers,et al.  Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[60]  S. Ritter,et al.  Encapsulation of FITC to monitor extracellular pH: a step towards the development of red blood cells as circulating blood analyte biosensors , 2011, Biomedical optics express.

[61]  Dongmei Sun,et al.  Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[62]  Ronnie H. Fang,et al.  A biomimetic nanosponge that absorbs pore-forming toxins , 2013, Nature nanotechnology.

[63]  Antonella Antonelli,et al.  Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents. , 2011, Nanomedicine.

[64]  M. Watanabe,et al.  Regulatory T cells and breast cancer: implications for immunopathogenesis , 2010, Cancer and Metastasis Reviews.

[65]  E. Terreno,et al.  Lanthanide-loaded erythrocytes as highly sensitive chemical exchange saturation transfer MRI contrast agents. , 2014, Journal of the American Chemical Society.

[66]  Jennifer Sturgis,et al.  A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. , 2007, Nano letters.

[67]  P. Kantoff,et al.  Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer , 2012, Cancer Immunology, Immunotherapy.

[68]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[69]  M. Andreeff,et al.  Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer. , 2013, Cytotherapy.

[70]  Guimei Zhang,et al.  Delivery of chemotherapeutic drugs in tumour cell-derived microparticles , 2012, Nature Communications.

[71]  Hon-Man Liu,et al.  Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells , 2010, Nanotechnology.

[72]  Silvia Maria Doglia,et al.  Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[73]  Y. Tabata,et al.  Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection. , 2012, Molecular pharmaceutics.

[74]  Zhiping Zhang,et al.  Lipid-enveloped hybrid nanoparticles for drug delivery. , 2013, Nanoscale.

[75]  Ronnie H. Fang,et al.  Nanoparticle-detained toxins for safe and effective vaccination , 2013, Nature nanotechnology.

[76]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[77]  Ronnie H. Fang,et al.  'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. , 2013, Nanoscale.

[78]  Laura Chiarantini,et al.  Erythrocytes deliver Tat to interferon‐γ‐treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro , 2002, Journal of leukocyte biology.

[79]  QUAN LIU,et al.  Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[80]  Y. Tao,et al.  A novel therapeutic system for malignant glioma: nanoformulation, pharmacokinetic, and anticancer properties of cell-nano-drug delivery. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[81]  S. Kesari,et al.  Distearoyl Anchor‐Painted Erythrocytes with Prolonged Ligand Retention and Circulation Properties In Vivo , 2014, Advanced healthcare materials.

[82]  Jörg Huwyler,et al.  Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[83]  Y. Sung,et al.  The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity , 2011, Gene Therapy.

[84]  Robert Franco,et al.  International seminar on the red blood cells as vehicles for drugs , 2012, Expert opinion on biological therapy.

[85]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[86]  A. Bangham Surrogate cells or Trojan horses. The discovery of liposomes. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[87]  Y. Sung,et al.  Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells. , 2011, Human gene therapy.

[88]  Robert Langer,et al.  Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies. , 2013, Molecular pharmaceutics.

[89]  Kostas Kostarelos,et al.  Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. , 2011, Accounts of chemical research.

[90]  H. Choi,et al.  Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. , 2013, Biomaterials.

[91]  A. Kabanov,et al.  Cell-mediated drug delivery to the brain , 2013 .

[92]  M. Stojkovic,et al.  Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice , 2013, Scientific Reports.

[93]  Jaesung Park,et al.  Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. , 2013, ACS nano.

[94]  G. Bosman,et al.  Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion , 2008, Transfusion medicine.

[95]  J. M. Lanao,et al.  Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis. , 2004, Blood cells, molecules & diseases.

[96]  P. A. van der Ley,et al.  Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes. , 2014, Vaccine.

[97]  Hamid Cheshmi Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[98]  Xingzhong Zhao,et al.  Core-shell supramolecular gelatin nanoparticles for adaptive and "on-demand" antibiotic delivery. , 2014, ACS nano.

[99]  J. Hubbell,et al.  Engineering antigens for in situ erythrocyte binding induces T-cell deletion , 2012, Proceedings of the National Academy of Sciences.

[100]  J. Hubbell,et al.  Translating materials design to the clinic. , 2013, Nature materials.

[101]  Ronnie H. Fang,et al.  Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. , 2013, Nanoscale.

[102]  N. Guérin,et al.  Red blood cells as innovative antigen carrier to induce specific immune tolerance. , 2013, International journal of pharmaceutics.

[103]  Lei Chen,et al.  Tumor microenviroment and hepatocellular carcinoma metastasis , 2013, Journal of gastroenterology and hepatology.

[104]  J. Berlin,et al.  Gold Nanoparticle‐Loaded Neural Stem Cells for Photothermal Ablation of Cancer , 2013, Advanced healthcare materials.

[105]  Kam W. Leong,et al.  Whole Blood Cells Loaded with Messenger RNA as an Anti‐Tumor Vaccine , 2014, Advanced healthcare materials.

[106]  M. Wood,et al.  Exosome nanotechnology: An emerging paradigm shift in drug delivery , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[107]  Weihong Tan,et al.  Nanotechnology in therapeutics : a focus on nanoparticles as a drug delivery system Review , 2008 .

[108]  Dongmei Sun,et al.  A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[109]  J. Shang,et al.  Adenoviral‐mediated interleukin‐18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats , 2009, Cell biology international.

[110]  Samir Mitragotri,et al.  Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. , 2013, ACS nano.

[111]  C. Lewis,et al.  Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. , 2004, Blood.

[112]  F. Dosio,et al.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.

[113]  M. Magnani,et al.  Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. , 2002, Antiviral research.

[114]  M. Rouini,et al.  In Vitro Characterization of Human Intact Erythrocytes Loaded by Enalaprilat , 2001, Drug delivery.

[115]  W. Grizzle,et al.  Exosomes are endogenous nanoparticles that can deliver biological information between cells. , 2013, Advanced drug delivery reviews.

[116]  T. Pellegrino,et al.  Cell-derived vesicles as a bioplatform for the encapsulation of theranostic nanomaterials. , 2013, Nanoscale.

[117]  M. Magnani,et al.  Preparation and characterization of biotinylated red blood cells , 1994, Biotechnology and applied biochemistry.

[118]  J. Xiang,et al.  GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responses. , 2011, Vaccine.

[119]  Mehrdad Hamidi,et al.  Applications of carrier erythrocytes in delivery of biopharmaceuticals. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[120]  Mauro Magnani,et al.  Drug delivery by red blood cells , 2011, IUBMB life.

[121]  Mingying Yang,et al.  Stem Cells Loaded with Nanoparticles as a Drug Carrier for In Vivo Breast Cancer Therapy , 2014, Advanced materials.

[122]  J. C. Diez,et al.  In vivo behaviour of rat band 3 cross-linked carrier erythrocytes. , 1998, Biochimie.

[123]  S. Feng,et al.  Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success , 2013, Expert opinion on drug delivery.

[124]  Xiaoqi Sun,et al.  Multifunctional Theranostic Red Blood Cells For Magnetic‐Field‐Enhanced in vivo Combination Therapy of Cancer , 2014, Advanced materials.

[125]  Yuliang Zhao,et al.  A membrane vesicle-based dual vaccine against melanoma and Lewis lung carcinoma. , 2012, Biomaterials.

[126]  C Lizano,et al.  In vitro study of alcohol dehydrogenase and acetaldehyde dehydrogenase encapsulated into human erythrocytes by an electroporation procedure. , 1998, Biochimica et biophysica acta.

[127]  Ronnie H. Fang,et al.  Clearance of pathological antibodies using biomimetic nanoparticles , 2014, Proceedings of the National Academy of Sciences.

[128]  E. L. Wright,et al.  Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[129]  J. Berlin,et al.  Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution. , 2014, Future oncology.

[130]  C. Ménager,et al.  Red blood cells decorated with functionalized core-shell magnetic nanoparticles: elucidation of the adsorption mechanism. , 2013, Chemical communications.

[131]  R H Glew,et al.  Enzyme loading of erythrocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[132]  Alexander M Seifalian,et al.  The application of exosomes as a nanoscale cancer vaccine , 2010, International journal of nanomedicine.

[133]  N. Jain,et al.  Erythrocytes as carriers of primaquine-preparation: characterization and evaluation , 1992 .

[134]  R. Weissleder,et al.  89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. , 2011, Bioconjugate chemistry.

[135]  Samir Mitragotri,et al.  Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[136]  U. Şahin,et al.  Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. , 2010, Cancer research.

[137]  S. Shimato,et al.  Human neural stem cells transduced with IFN-β and cytosine deaminase genes intensify bystander effect in experimental glioma , 2010, Cancer Gene Therapy.

[138]  Harvey F Lodish,et al.  Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes , 2014, Proceedings of the National Academy of Sciences.

[139]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[140]  P. Lønning,et al.  Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.

[141]  Khalid Shah,et al.  Stem cell-based therapies for cancer treatment: separating hope from hype , 2014, Nature Reviews Cancer.

[142]  Helmuth Möhwald,et al.  Nanoplasmonics for dual-molecule release through nanopores in the membrane of red blood cells. , 2012, ACS nano.

[143]  Pieter Vader,et al.  Extracellular vesicles as drug delivery systems: lessons from the liposome field. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[144]  R. Flower,et al.  Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells. , 2008, Investigative ophthalmology & visual science.